Latest filing published 02 Apr 2026 for Organon & Co.. Read the official filing
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kirke Weaver discloses dealings in Organon & Co. to SEC (Form 4). In total, 17 filings cover trades dated from 28 February 2023 to 31 March 2026.
The open-market record is one-sided, with 2 purchases worth €111k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 share grants and 11 option exercises.
The record was last updated on 2 April 2026 with an option exercise in Organon & Co. The most recent open-market purchase was published on 7 May 2025, 529 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations